India’s National Pharmaceutical Pricing Authority (NPPA) has announced its latest round of ceiling prices for medications, this time capping the prices of 51 medications and 2 formulations for anti-coagulant therapeutics. The other drugs covered include 24 diabetes treatments. The NPPA is India’s key drug pricing regulatory body, in charge of setting ceiling prices for medications and formulations.
According to Money Control News, “The ceiling price is the amount fixed by the government for Scheduled Formulations in accordance with the provisions of the Drugs (Prices Control) Order, 2013. It is the maximum price for retailers (excluding GST, if any) for a given product.”
To read more, click here.
(Source: Money Control News, June 30th, 2023)